CCL2 and type 2 diabetes mellitus: Compared to the CON group, the T2DM-SED group exhibited significantly elevated mRNA expression of pro-inflammatory cytokines IL-6, TNF-α, and IL-15 (Figure 3A–C), as well as chemokines CCL2 and CCL5 (Figure 3D,E).